Cargando…
bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.
Thyroid carcinomas are heterogeneous in terms of histology, clinical presentation, treatment response and prognosis. Since bcl-2 and p53 gene alterations are frequently involved in both lymphoid and epithelial malignancies, we analysed the expression of bcl-2, p53 and proliferating cell nuclear anti...
Autores principales: | Pollina, L., Pacini, F., Fontanini, G., Vignati, S., Bevilacqua, G., Basolo, F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074326/ https://www.ncbi.nlm.nih.gov/pubmed/8546897 |
Ejemplares similares
-
Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.
por: Basolo, F., et al.
Publicado: (1997) -
Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.
por: Fontanini, G., et al.
Publicado: (1995) -
Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
por: Fontanini, G., et al.
Publicado: (1997) -
Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization
por: Boldrini, L, et al.
Publicado: (2000) -
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
por: Fontanini, G, et al.
Publicado: (1999)